Labcyte Receives 22nd Patent for Restoration of Fluid Volume and Composition Using Acoustics
News Sep 05, 2005
Labcyte Inc. has received U.S. Patent 6,932,097, its 22nd patent, which discloses how to use acoustics to monitor the composition and volume of a fluid and maintain those parameters via active fluid supplementation.
In many applications, both chemical and biological, fluid composition can change because of evaporation or absorbance of water from the atmosphere.
“Applications are numerous for the technology described in this patent. High on the list is the active control of the solvent composition in chemical libraries used in the pharmaceutical industry,” said Richard Ellson, Chief Technical Officer.
He adds, “Dimethyl sulfoxide (DMSO) is the solvent of choice because it so readily dissolves so many different chemicals. Unfortunately, the use of DMSO can lead to various problems. DMSO can evaporate from the plates used to store chemical libraries.”
“Even heat-sealed plates can lose significant volume especially along the edges of the plate. At a minimum, this causes the concentration of the drug candidate to rise as the DMSO is lost.”
“To make the situation worse, water can enter the wells and lower the concentration. This occurs since DMSO is very hygroscopic with the ability to absorb its own weight in water.”
“Depending on the environmental conditions, this absorbed water can dilute of the drug candidates by as much as 50%, but worse yet, the water in the DMSO can promote precipitation or accelerate degradation of many chemical compounds in pharmaceutical libraries.”
“False negatives are a common result when compound concentrations drop towards zero. With forces in play that both increase concentration and lower concentration, how do you know what you have?”
“The techniques taught in this patent provide the researcher with a way to monitor both the volume and hydration of DMSO in sample wells.”
“Just as importantly, it also provides the mechanism to compensate actively for both loss due to evaporation and hydration due to laboratory humidity.”
“Acoustic transfer of new DMSO to the reservoir well can compensate directly for evaporation. Addition of pure DMSO also reduces the concentration of water to levels that prevent chemical precipitation.”
“This patent describes how researchers can take active control of the library samples rather than being a passive subject of laboratory conditions and lets the researcher get better answers in compound screening.”
Labcyte illustrated this process for a 384-well microplate initially filled with relatively “dry” DMSO solutions and then allowed to hydrate in a normal lab environment.
Next, the microplate wells were exposed to a dry air stream, leading to a loss of both the water and some DMSO.
Acoustic auditing was used to determine change in volume of DMSO and water from the initial samples.
The missing materials were transferred back into each well by acoustic transfer to restore the samples to their starting composition.
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019